18F-PSMA is a highly sensitive tracer, capable of detecting very small prostate cancer lesions, particularly in cases where more typical imaging techniques have yielded negative results.

This ability to highlight cancer cells more clearly increases the potential for earlier detection. This is vital for more accurate cancer staging and effective treatment planning.

Alliance Medical are proud to be at the forefront of PET-CT diagnostics. Our reliable and readily available supply of 18F-PSMA tracer, represents a significant stride towards improving patient outcomes in the fight against prostate cancer.

As the healthcare industry continues to evolve, Alliance Medical's introduction of the F18-PSMA tracer at its PET-CT centres marks a pivotal moment in cancer diagnostics. This development promises to bring hope and improved care to countless individuals facing the challenges of prostate cancer.